Provided By PR Newswire
Last update: Mar 25, 2025
Inspira's innovative FDA-cleared INSPIRA™ ART100 system was successfully deployed at premier U.S. hospital, with systems in place for clinical use
RA'ANANA, Israel, March 25, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it has successfully completed the installation, training program and operational readiness for its INSPIRA ART100 system for cardiopulmonary bypass procedures at one of New York's premier hospitals.
Read more at prnewswire.comNASDAQ:IINN (10/31/2025, 12:42:57 PM)
0.94
+0.01 (+1.08%)
Find more stocks in the Stock Screener



